Stoke therapeutics, inc. (STOK)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Dec'18
Assets
Current assets:
Cash and cash equivalents

211,288

222,471

233,049

242,680

105,399

Prepaid expenses and other current assets

4,342

3,281

3,255

1,505

548

Interest receivable

144

281

376

260

196

Total current assets

215,774

226,033

236,680

244,445

106,143

Restricted cash

205

205

205

205

204

Operating lease right-of-use assets

1,900

-

-

-

-

Property and equipment, net

2,962

2,512

1,942

1,722

1,192

Total assets

220,841

228,750

238,827

246,372

107,539

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

1,779

751

1,789

1,238

1,071

Accrued and other current liabilities

3,676

3,350

3,127

3,580

1,396

Total current liabilities

5,455

4,101

4,916

4,818

2,467

Long term liabilities

1,044

221

228

18

4

Total liabilities

6,499

4,322

5,144

4,836

2,471

Stockholders’ equity
Common stock, par value of $0.0001 per share; 300,000,000 shares authorized, 32,967,350 and 32,861,842 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

3

3

3

3

-

Additional paid-in capital

283,413

282,460

281,555

280,804

130,776

Accumulated deficit

-69,074

-58,035

-47,875

-39,271

-25,710

Total stockholders’ equity

214,342

224,428

233,683

241,536

105,068

Total liabilities and stockholders’ equity

220,841

228,750

238,827

246,372

107,539

Convertible Preferred Stock
Preferred Stock, value

-

-

-

-

2

Total stockholders’ equity

-

-

-

-

2